Patent · US Expired

In vitro diagnostic assays for the detection of HIV-1 or HIV-2 employing viral-specific antigens and antibodies

US5830641A · kind A · utility

9Cited by
7References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 17, 1994
Grant dateNov 3, 1998
Priority date
Expiry dateMar 17, 2014

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a new class of retroviruses, designated by HIV-2, of which samples have been deposited to the ECACC under numbers 87.01.1001 and 87.01.1002 and to the NCIB under numbers 12.398 and 12.399. It relates also to antigens capable to be obtained from this virus, particularly proteins p12, p16, p26 and gp140. These various antigens can be used for the diagnosis of the disease, especially by contacting these antigens with a serum of a patient submitted to the diagnosis. It relates to immunogenic compositions containing more particularly the glycoprotein gp140. Finally it concerns nucleotidic sequences, which can be used especially as hybridization probes, derived from the RNA of HIV-2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.